Puma Biotechnology (PBYI) Current Leases (2019 - 2026)
Puma Biotechnology (PBYI) posted Current Leases of $125000.0 for Q1 2026, down 90.49% on a QoQ basis from $1.3 million in Q4 2025, and down 97.82% year-over-year from $5.7 million in Q1 2025.
Puma Biotechnology (PBYI) Current Leases (2019 - 2026) Analysis & Trends
Puma Biotechnology's Current Leases history runs 8 years deep, the most recent figure standing at $125000.0 for Q1 2026.
- Quarterly Current Leases fell 97.82% year-over-year to $125000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125000.0 (down 97.82% YoY) and the FY2025 annual result came in at $1.3 million, down 76.28% from the prior year.
- Current Leases was $125000.0 for Q1 2026 at Puma Biotechnology, down from $1.3 million in the prior quarter.
- Across five years, Current Leases topped out at $5.7 million in Q1 2025 and bottomed at $125000.0 in Q1 2026.
- A 5-year average of $4.1 million and a median of $4.4 million in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases gained 16.2% — and 2026, when it plunged 97.82%.
- Puma Biotechnology's Current Leases stood at $4.1 million in 2022, then grew by 15.94% to $4.8 million in 2023, then rose by 15.42% to $5.5 million in 2024, then sank by 76.28% to $1.3 million in 2025, then sank by 90.49% to $125000.0 in 2026.
- Business Quant data shows PBYI's Current Leases at $125000.0 in Q1 2026, $1.3 million in Q4 2025, and $2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn | 125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125,000.00 |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 2.47 Mn |
| Jun 30, 2025 | 4.36 Mn |
| Mar 31, 2025 | 5.74 Mn |
| Dec 31, 2024 | 5.54 Mn |
| Sep 30, 2024 | 5.35 Mn |
| Jun 30, 2024 | 5.16 Mn |
| Mar 31, 2024 | 4.98 Mn |
| Dec 31, 2023 | 4.80 Mn |
| Sep 30, 2023 | 4.63 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Mar 31, 2023 | 4.30 Mn |
| Dec 31, 2022 | 4.14 Mn |
| Sep 30, 2022 | 3.99 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Mar 31, 2022 | 3.70 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Sep 30, 2021 | 3.45 Mn |
| Jun 30, 2021 | 3.34 Mn |